BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 30711963)

  • 1. Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1.
    Mehlan J; Schüttauf F; Salamon JM; Kordes U; Friedrich RE; Mautner VF
    Anticancer Res; 2019 Feb; 39(2):827-831. PubMed ID: 30711963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant meningioma and glioma within the same optic nerve in neurofibromatosis type 1.
    Büyükkapu-Bay S; Akça A; Karadoğan M; Çorapçioğlu F; Anik Y
    J Child Neurol; 2014 Mar; 29(3):385-8. PubMed ID: 23420652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular manifestations of neurofibromatosis 1--m. Recklinghausen.
    Gromova M; Gerinec A
    Bratisl Lek Listy; 2008; 109(6):259. PubMed ID: 18700436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis type 1 and hypertension in pediatrics: case report].
    Demarchi I; Genoni G; Prodam F; Petri A; Busti A; Cortese L; Negro M; Bellone S; Acucella G; Bona G
    Minerva Pediatr; 2011 Aug; 63(4):335-9. PubMed ID: 21909069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations of neurofibromatosis 1 - m. Recklinghausen.
    Gromova M; Gerinec A
    Bratisl Lek Listy; 2008; 109(5):246-7. PubMed ID: 18634177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I neurofibromatosis: a geno-oculo-dermatologic update.
    Schnur RE
    Curr Opin Ophthalmol; 2012 Sep; 23(5):364-72. PubMed ID: 22871881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort.
    Blanchard G; Lafforgue MP; Lion-François L; Kemlin I; Rodriguez D; Castelnau P; Carneiro M; Meyer P; Rivier F; Barbarot S; Chaix Y;
    Eur J Paediatr Neurol; 2016 Mar; 20(2):275-281. PubMed ID: 26774135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic glioma warranting treatment in children.
    Kaufman LM; Doroftei O
    Eye (Lond); 2006 Oct; 20(10):1149-64. PubMed ID: 17019413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial unilateral lentiginosis is mosaic neurofibromatosis type 1 or not?
    Yaşar Ş; Ersanli A; Göktay F; Aytekin S; Cebeci D; Güneş P
    J Dermatol; 2017 Jan; 44(1):29-35. PubMed ID: 27439996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey.
    Sharafi P; Varan A; Ersoy-Evans S; Ayter S
    Childs Nerv Syst; 2024 Feb; 40(2):511-515. PubMed ID: 37401974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic Pathway Gliomas in Neurofibromatosis Type 1.
    Campen CJ; Gutmann DH
    J Child Neurol; 2018 Jan; 33(1):73-81. PubMed ID: 29246098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis 1-associated optic pathway gliomas.
    Shofty B; Ben Sira L; Constantini S
    Childs Nerv Syst; 2020 Oct; 36(10):2351-2361. PubMed ID: 32524182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R
    J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children].
    Syrbe S; Eberle K; Strenge S; Bernhard MK; Herbertz S; Bierbach U; Hirsch W; Froster UG; Kiess W; Merkenschlager A
    Klin Padiatr; 2007; 219(6):326-32. PubMed ID: 18183640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report.
    Mikirova N; Hunnunghake R; Scimeca RC; Chinshaw C; Ali F; Brannon C; Riordan N
    Am J Case Rep; 2016 Oct; 17():774-781. PubMed ID: 27773919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.